However, TFE3 gene breaks down at Xp11.2, and equilibrium translocations with ASPL, PSF, and other genes form new fusion genes, contributing to TFE3 or TFEB fusion gene formation and their high expression in vivo, thus causing renal cell carcinoma [2–6]. This evidence concerns the gene TFEB and renal cell carcinoma.